Featured Whitepaper

RANDOX LABORATORIES:
The Global Economic Burden of STIs & The Impact of the COVID-19 Pandemic on Sexual Health Download Whitepaper

Download Mobile App

Video Library

Events

more events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

05 Dec 2022 - 08 Dec 2022

BSI Congress 2022 – British Society for Immunology

06 Dec 2022 - 08 Dec 2022

8th Annual Conference of the Saudi Society for Clinical Chemistry

10 Dec 2022 - 13 Dec 2022

64th Annual Meeting & Exposition of the American Society of Hematology (ASH)

Partner Sites

HospiMedica

Next-Gen POC Whole Blood Hemostasis System Recognizes Specific Needs of EDs and ORs

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Biocompatible Scaffolds Made From Unique Hybrid Materials Can Repair Spinal Cord Tissue

Handheld Lab to Enable Faster, Cheaper Point-of-Need Bacterial Infection Identification

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

POC Blood Test Analyzer Performs CBC in Five Minutes

By LabMedica International staff writers
Posted on 23 May 2022

Image: HemoScreen POC blood test analyzer makes testing simple and accessible anywhere (Photo courtesy of PixCell Medical)

The world's first and only lab-quality, portable plug-and-play Complete Blood Count (CBC) analyzer allows real-time blood testing to be performed by anyone, anywhere, providing critical health data on the spot. This facilitates fast diagnostic results and data-driven disease management decisions.

PixCell Medical Technologies, Ltd.’s (Yokne'am Illit, Israel) HemoScreen hematology analyzer is the only 5-part differential CBC analyzer that is FDA-cleared, CE-marked and TGA-approved for point-of-care use offers clinically proven lab-accurate readings of 20 standard blood count parameters within five minutes, with just one finger-prick of blood. PixCell's HemoScreen delivers lab-accurate diagnostic information that alloes healthcare professionals to make rapid and clinically reliable decisions supported by real-time data.

The portable point of care hematology analyzer combines flow cytometry and digital imaging in a single platform for CBC and WBC 5-part differential. HemoScreen employs a patented, disposable cartridge preloaded with all necessary reagents. This reduces reagent waste and eliminates the need for maintenance and calibration, providing CBC results as well as comprehensive abnormal cell flagging for earlier detection of infection and certain cancer types.

“PixCell has transformed routine blood testing by combining novel microfluidics, machine learning and AI into a point-of-care instrument that anyone can operate,” said Dr. Avishay Bransky, co-founder and CEO of PixCell Medical. “Our breakthrough technology is allowing lab-grade testing to become independent from central laboratories and highly skilled experts, putting data in the hands of the medical staff who need it most, when they need it and where they need it.”

Related Links:
PixCell Medical Technologies, Ltd.